Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 6.8% – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN)’s share price was up 6.8% during mid-day trading on Wednesday . The stock traded as high as $12.68 and last traded at $12.50. 3,397 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 44,826 shares. The stock had previously closed at $11.70.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Anbio Biotechnology has an average rating of “Hold”.

Anbio Biotechnology Trading Down 0.4%

The company has a 50 day moving average of $22.82.

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.